Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 2/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.37 |
| ▸ | ACP1 | P24666 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.34 |
| ▸ | NMT1 | P30419 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22894973 | 0.82 | GPR119 (0.54) | — | |
| SCHEMBL20068598 | 0.80 | ITGB3 (0.43) | CHEK1PDK1ITGB3ITGA2B | |
| SCHEMBL22284325 | 0.79 | ITGB3 (0.39) | CHEK1PDK1ITGB3ITGA2B | |
| SCHEMBL20077271 | 0.77 | NR1H2 (0.54) | NAMPTCHRM1 | |
| SCHEMBL18872731 | 0.76 | HCAR3 (0.41) | — | |
| Trifluoroacetic Acid SCHEMBL22284336 | 0.74 | ITGB3 (0.39) | CHEK1PDK1ITGB3ITGA2B | |
| SCHEMBL20077107 | 0.70 | NMT1 (0.45) | PDK1ITGB3ITGA2BNMT1 | |
| SCHEMBL18931047 | 0.70 | PDK1 (0.38) | CHEK1PDK1 | |
| SCHEMBL25547122 | 0.69 | ITGB3 (0.47) | PDK1ITGB3ITGA2B | |
| SCHEMBL22894997 | 0.69 | THRB (0.47) | PDK1CHRM1NMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894775-B2 | Piperidine derivatives as liver X receptor beta agonists, compositions, and their use | MERCK SHARP & DOHME CORP. (US) | 2021-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894775-B2 | Piperidine derivatives as liver X receptor beta agonists, compositions, and their use | NR1H2, NR1H3, ADRB1 | NAMPT 3925/4885CHEK1 4627/4885PDK1 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.